Clinical Trial Update: Hypofractionated Radiation Therapy Combined With Concurrent Chemotherapy for Patients With Non-small Cell Lung Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating hypofractionated radiation therapy with concurrent chemotherapy for non-small cell lung cancer; the study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: LIN QIANG | Conditions: Non-small Cell Lung Cancer | Phase 2 | Status: COMPLETED